Previous work regarding the contribution of CD36 and FATP4 to hepatic LCFA uptake as a possible player in NAFLD or NASH found that overexpression of FATP2 and FATP4 in cells was associated with elevated oleate uptake in comparison with control cells. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.